DrugCite
Search

HOLOXAN BAXTER

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Holoxan Baxter Adverse Events Reported to the FDA Over Time

How are Holoxan Baxter adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Holoxan Baxter, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Holoxan Baxter is flagged as the suspect drug causing the adverse event.

Most Common Holoxan Baxter Adverse Events Reported to the FDA

What are the most common Holoxan Baxter adverse events reported to the FDA?

Encephalopathy
36 (6.5%)
Renal Failure
15 (2.71%)
Renal Failure Acute
14 (2.53%)
Confusional State
13 (2.35%)
Sepsis
13 (2.35%)
Bone Marrow Failure
12 (2.17%)
Nausea
12 (2.17%)
Renal Tubular Disorder
12 (2.17%)
Thrombocytopenia
11 (1.99%)
Vomiting
11 (1.99%)
Hallucination
10 (1.81%)
Show More Show More
Hypokalaemia
10 (1.81%)
Mucosal Inflammation
10 (1.81%)
Febrile Bone Marrow Aplasia
9 (1.62%)
Muscle Spasms
8 (1.44%)
Neutropenia
8 (1.44%)
Fanconi Syndrome
7 (1.26%)
Febrile Neutropenia
7 (1.26%)
Neurotoxicity
7 (1.26%)
Pyrexia
7 (1.26%)
Toxic Encephalopathy
7 (1.26%)
Atrial Fibrillation
6 (1.08%)
Ejection Fraction Decreased
6 (1.08%)
Epilepsy
6 (1.08%)
Fungal Infection
6 (1.08%)
Gastritis
6 (1.08%)
Leukopenia
6 (1.08%)
Pancytopenia
6 (1.08%)
Pleural Effusion
6 (1.08%)
Cardiac Failure
5 (.9%)
Dyspnoea
5 (.9%)
Dysuria
5 (.9%)
Abnormal Behaviour
4 (.72%)
Cerebellar Syndrome
4 (.72%)
Cytolytic Hepatitis
4 (.72%)
Diarrhoea
4 (.72%)
Hyperpyrexia
4 (.72%)
Interstitial Lung Disease
4 (.72%)
Intracardiac Thrombus
4 (.72%)
Muscle Twitching
4 (.72%)
Neuropathy Peripheral
4 (.72%)
Pulmonary Fibrosis
4 (.72%)
Renal Failure Chronic
4 (.72%)
Respiratory Failure
4 (.72%)
Stomatitis
4 (.72%)
Unresponsive To Stimuli
4 (.72%)
Angioedema
3 (.54%)
Aphasia
3 (.54%)
Ascites
3 (.54%)
Asterixis
3 (.54%)
Asthenia
3 (.54%)
Blood Creatinine Increased
3 (.54%)
Blood Pressure Decreased
3 (.54%)
Catatonia
3 (.54%)
Cerebral Infarction
3 (.54%)
Coagulopathy
3 (.54%)
Convulsion
3 (.54%)
Cough
3 (.54%)
Drug Exposure During Pregnancy
3 (.54%)
Extrapyramidal Disorder
3 (.54%)
Headache
3 (.54%)
Metastases To Spine
3 (.54%)
Metastatic Neoplasm
3 (.54%)
Pneumonia
3 (.54%)
Renal Impairment
3 (.54%)
Rhabdomyolysis
3 (.54%)
Urine Output Decreased
3 (.54%)
Altered State Of Consciousness
2 (.36%)
Aspergillosis
2 (.36%)
Atrial Flutter
2 (.36%)
Bacterial Infection
2 (.36%)
Brain Oedema
2 (.36%)
Conjunctivitis
2 (.36%)
Crying
2 (.36%)
Dehydration
2 (.36%)
Depression
2 (.36%)
Diffuse Large B-cell Lymphoma
2 (.36%)
Disseminated Intravascular Coagulat...
2 (.36%)
Drug Interaction
2 (.36%)
Electrolyte Imbalance
2 (.36%)
Escherichia Sepsis
2 (.36%)
Feeling Of Despair
2 (.36%)
Gait Disturbance
2 (.36%)
General Physical Health Deteriorati...
2 (.36%)
Hyperglycaemia
2 (.36%)
Hypernatraemia
2 (.36%)
Hypocalcaemia
2 (.36%)
Hyponatraemia
2 (.36%)
Incorrect Drug Administration Rate
2 (.36%)
Infusion Site Abscess
2 (.36%)
Infusion Site Extravasation
2 (.36%)
Lung Disorder
2 (.36%)
Metabolic Disorder
2 (.36%)
Paraesthesia
2 (.36%)
Persecutory Delusion
2 (.36%)
Pulmonary Embolism
2 (.36%)
Sopor
2 (.36%)
Status Epilepticus
2 (.36%)
Transitional Cell Carcinoma
2 (.36%)
Vertigo
2 (.36%)
Abdominal Pain
1 (.18%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Holoxan Baxter, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Holoxan Baxter is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Holoxan Baxter

What are the most common Holoxan Baxter adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Holoxan Baxter, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Holoxan Baxter is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Holoxan Baxter According to Those Reporting Adverse Events

Why are people taking Holoxan Baxter, according to those reporting adverse events to the FDA?

Sarcoma
22
Rhabdomyosarcoma
12
Bone Sarcoma
12
Non-hodgkins Lymphoma
10
Product Used For Unknown Indication
7
Ewings Sarcoma
7
Show More Show More
Testis Cancer
7
Leiomyosarcoma
7
Lymphoma
5
Drug Use For Unknown Indication
5
Diffuse Large B-cell Lymphoma
5
Endometrial Sarcoma
5
B-cell Lymphoma
4
Testicular Germ Cell Cancer
4
Ovarian Cancer
4
Hodgkins Disease
4
Lung Adenocarcinoma
3
Osteosarcoma Metastatic
3
Precursor T-lymphoblastic Lymphoma/...
3
Osteosarcoma Localised
2
Metastatic Uterine Cancer
2
Teratoma Of Testis
2
Uterine Cancer
2
T-cell Lymphoma
2
B-cell Lymphoma Refractory
2
Hodgkins Disease Stage Iv
2
Drug Exposure During Pregnancy
2
Liposarcoma Metastatic
2
Liposarcoma
2
Acute Lymphocytic Leukaemia
2
Chemotherapy
2
Neoplasm Malignant
2
Desmoplastic Small Round Cell Tumou...
2
Metastases To Central Nervous Syste...
1
Sarcoma Uterus
1
Small Cell Lung Cancer Stage Unspec...
1
Metastases To Lung
1
Vulval Cancer
1
Malignant Lymphoid Neoplasm
1
Liposarcoma Recurrent
1
Teratoma
1
Bronchial Carcinoma
1
Diffuse Large B-cell Lymphoma Stage...
1
Transitional Cell Carcinoma
1
Leiomyosarcoma Recurrent
1
Angiosarcoma
1
Vaginal Cancer
1
Synovial Sarcoma
1
Malignant Mediastinal Neoplasm
1
Colon Cancer Stage Iii
1
Non-hodgkins Lymphoma Recurrent
1

Holoxan Baxter Case Reports

What Holoxan Baxter safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Holoxan Baxter. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Holoxan Baxter.